Year: 2021

METTAWA, Ill., Dec. 28, 2021 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) has announced that it will not participate in-person at the 2022 Consumer Electronics Show. The Company had planned an in-person exhibit in the Las Vegas Convention Center’s West Hall. “Due to the quickly evolving COVID-19 infection rates and uncertainty around the omicron variant, Brunswick Corporation has made the decision not to participate in-person at CES 2022,” said Dave Foulkes, Brunswick Corporation CEO. “We value the importance and influence of the Consumer Electronics Show and will continue to participate virtually, showcasing our Next Wave strategy and many of our award-winning products through virtual and digital platforms including our virtual media days. We look forward to participating in-person at CES 2023.” Brunswick recently launched...

BEIJING, Dec. 28, 2021 (GLOBE NEWSWIRE) — Secoo Holding Limited (“Secoo” or the “Company”) (NASDAQ: SECO), Asia’s leading online integrated upscale products and services platform, today announced that its Board of Directors (the “Board”) has approved the appointment of Mr. Jianji Liu to the Board as an independent director and the resignation of each of Ms. Qi Zhu and Mr. Jian Wang from the post as a director of the Company, all effective December 28, 2021. Mr. Jianji Liu will also serve on the compensation committee as its chairman, the audit committee as its member and the nominating and corporate governance committee as its member, to replace Mr. Jian Wang’s positions on these committees of the Board. Mr. Jianji Liu has served as the general manager of Shenzhen Jinxin Guotou Fund Management Co., Ltd since January 2018. From...

New York, NY, Dec. 28, 2021 (GLOBE NEWSWIRE) — Global Tech Industries Group, Inc. (OTCQB: GTII) (“GTII” or the “Company”), www.gtii-us.com, a Nevada corporation, announced today that is has updated its warrant exercise instructions for warrants received as of the record date of April 1, 2021 (the “Warrants”). Warrant holders can obtain a copy of the updated warrant exercise instructions, as well as the Election to Purchase Warrant Shares form by visiting the GTII website or clicking here1. The updated warrant exercise instruction letter has been available on the GTII website since December 15, 2021. However, the Company recently learned that the banking information for exercise by wire transfer or Automated Clearing House (“ACH”) provided on the original warrant exercise letter dated April 9, 2021 has been compromised and is no...

Etisalat expands CloudTalk Enterprise Collaboration Solutions with innovative real time communications capabilities for vertical industry sectors powered by Kandy’s growing global partner ecosystem ATLANTA, Dec. 28, 2021 (GLOBE NEWSWIRE) — American Virtual Cloud Technologies, Inc.’s (AVCtechnologies) (Nasdaq: AVCT) Kandy Communications business unit (Kandy), a global leader in secure and intelligent cloud communications, today announced the growth of its partnership with Etisalat, one of the world’s leading telecom groups in emerging markets, along with new offerings enabling embedded communications in business applications for large enterprises in the region. The Etisalat CloudTalk and Business Edge, powered by Kandy’s Unified Communications and Collaboration platform, is a feature-rich, cloud-based, real-time communications solution...

BIRMINGHAM, Ala., Dec. 28, 2021 (GLOBE NEWSWIRE) — ServisFirst Bancshares, Inc. (NYSE: SFBS) is scheduled to announce earnings and operating results for the quarter and year ended December 31, 2021 on January 24, 2022 at 4 p.m. ET. The news release will be available at www.servisfirstbancshares.com. ServisFirst Bancshares, Inc. will host a live audio webcast to discuss earnings and results on Monday, January 24, 2022 beginning at 5:15 p.m. ET. The audio webcast can be accessed at www.servisfirstbancshares.com. A replay of the call will be available until February 4, 2022. About ServisFirst Bancshares, Inc. ServisFirst Bancshares, Inc. is a bank holding company based in Birmingham, Alabama. Through its subsidiary ServisFirst Bank, ServisFirst Bancshares, Inc. provides business and personal financial services from locations in Birmingham,...

RUTLAND, Vt., Dec. 28, 2021 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (NASDAQ: CWST), a regional solid waste, recycling and resource management services company, announced that on December 22, 2021, it entered into a $650 million Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent and swing line lender, Bank of America, N.A., Citizens Bank, N.A., JPMorgan Chase Bank N.A. and Comerica Bank as joint lead arrangers and joint bookrunners, and certain other agents and lenders (the “Credit Facility”). The Credit Facility matures on December 22, 2026 and replaces Casella’s prior $550 million credit facility. The Credit Facility provides for a term loan A facility in the amount of $350 million and a revolving credit facility in the principal amount of up to $300 million, with a $75 million sublimit...

READING, Pa., Dec. 28, 2021 (GLOBE NEWSWIRE) — EnerSys® (NYSE:ENS), the global leader in stored energy solutions for industrial applications, is proud to announce the successful integration of its ABSL™ Lithium-ion (Li-ion) batteries into the National Aeronautics and Space Administration (NASA) James Webb Space Telescope launch. As the successor to the iconic Hubble Space Telescope, Webb is the largest and most powerful space science telescope ever built, and is the result of an International collaboration between NASA and its partners the European Space Agency (ESA) and the Canadian Space Agency (CSA) and prime industry lead, Northrop Grumman. Webb launched on December 25th, 2021, was sent into orbit upon an Ariane 5 rocket from Europe’s Spaceport in French Guiana and will serve as the premier space observatory for the next decade. EnerSys...

BETHESDA, Md., Dec. 28, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, today announced the grant of an option to purchase 200,000 shares of the Gain’s common stock and of 200,000 restricted stock units of Gain’s common stock to Matthias Alder, its Chief Operating Officer. These awards were approved by the Compensation Committee of Gain’s Board of Directors and granted under the Gain Therapeutics, Inc. 2021 Inducement Equity Incentive Plan, with a grant date of December 23, 2021, as an inducement material to Mr. Alder to enter into an employment with Gain, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock...

PHILADELPHIA, PA, Dec. 28, 2021 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens and beyond, today announced that management will participate in the 2022 ICR Conference planned to be held at the JW Marriott Orlando Grande Lakes in Orlando, Florida. Joel Anderson, President and CEO, and Ken Bull, CFO, are currently scheduled to participate in a fireside chat on Monday, January 10, 2022 at 10:00 a.m. Eastern Time. The audio portion of the fireside chat will be webcast live at http://investor.fivebelow.com/. An archived replay will be available two hours after the conclusion of the live event. The company plans to release its holiday sales results on Monday, January 10, 2022 before the market open. About Five Below: Five Below is a leading high-growth value...

TORONTO, Dec. 28, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company“), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that it has filed an international patent application covering its Family 3 novel psychedelic compounds. Mindset’s Family 3 consists of certain compounds that have demonstrated half-lives extending well beyond those exhibited by comparable classical psychedelic drugs with no significant reduction in binding affinity at the serotonin 5-HT2A receptor. “Our family 3 compounds are substantially differentiated from the other families that we are pursuing in that we believe...